Grifols S.A. Logo

Grifols S.A.

Develops and produces plasma-derived medicines and biopharmaceutical solutions.

GRF | MC

Overview

Corporate Details

ISIN(s):
ES0171996087 (+4 more)
LEI:
959800HSSNXWRKBK4N60
Country:
Spain
Address:
Avenida de la Generalitat 152-158, 08174 Sant Cugat del Vallès

Description

Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 08:28
La EMA ha emitido el Certificado de Conformidad con la legislación comunitaria …
Spanish 200.2 KB
2025-09-12 00:00
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-06-13 00:00
Motivo de la notificación: Persona Estrechamente Vinculada
Spanish 91.4 KB
2025-06-06 00:00
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-05-19 00:00
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-05-16 00:00
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-05-12 17:36
Grifols anuncia la información financiera del primer trimestre de 2025
Spanish 1.3 MB
2025-05-06 12:54
Como continuación de la Información Privilegiada presentada por Grifols el 31 d…
Spanish 43.3 KB
2025-05-02 08:04
Convocatoria de la Junta General Ordinaria de Accionistas 2025 de Grifols, S.A.
Spanish 137.8 KB
2025-05-02 00:00
Convocatoria de la Junta General Ordinaria de Accionistas 2025 de Grifols, S.A.
Spanish 137.8 KB
2025-04-02 13:40
Brookfield Capital Partners realiza comunicación en relación a noticias de pren…
Spanish 86.2 KB
2025-04-02 11:30
Con respecto a la información publicada en ciertos medios de comunicación.
Spanish 39.1 KB
2025-03-31 08:57
El Consejo de Administración ha aprobado por unanimidad que su filial Grifols B…
Spanish 41.6 KB
2025-03-14 00:00
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-03-10 12:55
Grifols desea informar sobre cierta información publicada en un medio de comuni…
Spanish 54.6 KB

Automate Your Workflow. Get a real-time feed of all Grifols S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Grifols S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Grifols S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Camp4 Therapeutics Corp Logo
Develops RNA-based therapeutics to amplify protein expression for genetic diseases.
United States of America
CAMP
Camurus Logo
Develops and commercializes long-acting medicines for severe and chronic diseases.
Sweden
CAMX
Candel Therapeutics, Inc. Logo
Develops viral immunotherapies to activate the immune system to fight cancer.
United States of America
CADL
Can-Fite BioPharma Ltd. Logo
Clinical-stage biopharma developing oral small-molecule drugs targeting the A3AR.
Israel
CANF
Cannabotech Ltd. Logo
Develops therapies by integrating cannabinoids and medicinal mushroom extracts.
Israel
CNTC
Cannovum Cannabis AG Logo
Licensed importer, wholesaler, and manufacturer of medical cannabis products.
Germany
27N0
Cantargia Logo
Develops antibody therapies targeting IL1RAP for cancer and inflammatory diseases.
Sweden
CANTA
Cantourage Group SE Logo
Produces and distributes EU-compliant medical cannabis from international partners.
Germany
HIGH
CAPRICOR THERAPEUTICS, INC. Logo
A clinical-stage biotech developing cell and exosome-based biologics for serious diseases.
United States of America
CAPR
A clinical-stage biotech developing regenerative medicines for heart failure.
United Kingdom
N/A

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.